Preview Mode Links will not work in preview mode

Mar 28, 2022

Featuring perspectives from Dr Srdan Verstovsek, including the following topics:

  • Introduction (0:00)
  • Case: A man in his early 70s with JAK2-positive intermediate-risk myelofibrosis (MF), a CALR mutation and multiple comorbidities — Amany R Keruakous, MD, MS (11:52)
  • Case: A woman in her mid 70s with JAK2 V617F-positive primary MF treated with ruxolitinib — Bhavana (Tina) Bhatnagar, DO (22:51)
  • Case: A woman in her early 80s with primary MF and pancytopenia (Hb 7.2 g/dL, platelets 30,000uL) — Jeanne Palmer, MD (28:49)
  • Case: A man in his mid 60s with JAK2-positive primary MF and pancytopenia who develops recurrent herpes zoster on ruxolitinib — Niyati A Nathwani, MD (35:05)
  • Case: A man in his mid 60s with an unspecified myeloproliferative neoplasm, pancytopenia and a JAK2 mutation — Dr Bhatnagar (40:03)
  • Case: A man in his mid 60s with post-polycythemia vera MF and ASXL1, SRSF2 mutations — Dr Palmer (55:25)

CME information and select publications